UnitedHealth is having a challenging year in 2025, but investors are hopeful 2026 will be much better.
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFA29 Aug 2025, 21:45 UTC
AI-generated source summary
The analysis discusses United Health's difficult year and predicts a stock price range of $400-$430 by the end of 2026, based on a $21.74 EPS estimate for 2027, with data from Fiscal.ai. The current forward P/E is 18.92. Scenarios presented involve different forward P/E ratios. Investors might reward the firm once margins improve. The highest estimated price is $543.50, corresponding to a forward P/E of 25. The fail bound is set at $250.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.